Loop CAR-T Cells Target Heterogeneous Leukemia Antigens
New loop-structured CAR-T cells targeting CD38 and CD123 show enhanced activity against heterogeneous acute myeloid leukemia in preclinical models.
New loop-structured CAR-T cells targeting CD38 and CD123 show enhanced activity against heterogeneous acute myeloid leukemia in preclinical models.
A new pipeline called RIFTT integrates two fusion callers and novel scoring metrics to reduce false positives in tumor transcriptome ...
A literature review finds that machine learning and bioinformatics have improved AML classification and risk stratification, but clinical implementation remains ...
A patient with relapsed FLT3-mutated acute myeloid leukemia achieved a durable complete remission exceeding five years after switching to gilteritinib.
A systematic review of 13 early-phase clinical trials found that lysine-specific demethylase 1 inhibitors show biological activity and disease-specific signals ...
A new review examines how platelet-derived microparticles may worsen acute myeloid leukemia by transferring molecular cargo to cancer cells, and ...
A new review maps how FLT3 inhibitors became standard therapy across newly diagnosed and relapsed AML while trials test triplets, ...
An integrative single-cell and bulk transcriptomic analysis identified an eight-gene non-LSC17 companion program associated with LSC17-high acute myeloid leukemia and ...
A new study shows that both inhibiting and activating the metabolic enzyme PKM2 reduces nuclear accumulation of the protein, lowers ...
High CD84 expression correlates with venetoclax resistance in AML, and targeting the CD84-SESN2 pathway sensitized leukemia cells to the drug ...
A new in vitro study reports that APR-246 enhanced venetoclax's anti-proliferative and pro-apoptotic effects in TP53 R248Q-mutated AML cell lines, ...
A Mendelian randomization study finds that ferroptosis-related genes influence acute myeloid leukemia risk directly and indirectly through specific immune cell ...
A tRNA-derived RNA fragment elevated in acute myeloid leukemia promotes cell growth and survival by suppressing AGGF1 and is associated ...
A new review describes how the long non-coding RNA MALAT1 drives leukemia cell survival, proliferation and chemotherapy resistance in acute ...
A new review synthesizes the clinical evidence, toxicity profiles and resistance mechanisms behind six FDA-approved antibody-drug conjugates for blood cancers.
Researchers have developed Dolphyin, a combinatorial algorithm that infers 1-Dollo phylogenies from single-cell cancer sequencing data and proved that the ...
A new review proposes the EV–platelet–NET axis as a framework for AML marrow niche remodeling and examines investigational cell-hitchhiking nanotherapeutics.
A large EBMT registry analysis of 3385 adults with AML in remission and measurable residual disease found that haploidentical transplantation ...
A 55-CpG DNA methylation signature developed from bone marrow samples and validated in an independent cohort appears to predict AML ...
A correspondence in Blood Research raises four methodological concerns about a study linking HERV-K102 envelope deletion to pyroptosis in acute ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.